Insmed says it suspends revenue guidance

Insmed provides business update.insmed inc - directs employees, including commercial field force, to work from home and suspends revenue guidance.insmed inc - astrazeneca exercises exclusive option to develop ins1007 in chronic obstructive pulmonary disease or asthma.insmed inc - has observed no disruptions to date in its supply chain for production of arikayce.insmed inc - submits new drug application in japan for arikayce.insmed inc - believes it has adequate supply of finished product on hand to support its commercial efforts for at least next 7 months.insmed inc - has no current supply issues and continues to see use of arikayce.insmed - general uncertainty regarding impact of covid-19 on arikayce patient population and their physicians has led co to suspend 2020 revenue guidance.
INSM Ratings Summary
INSM Quant Ranking